FireTower Advisory Services

---

When traction stalls in biopharma, the issue is rarely lack of effort or capability. More often, strategy, targeting, and business development activity are misaligned with how biopharma teams actually make, justify, and time decisions.

FireTower works with solution providers to evaluate that alignment. Our work examines where a solution can be credibly considered, by whom, and under what conditions — including development stage, buyer readiness, budget and approval constraints, and decision authority.

We translate those evaluations into practical guidance for leaders and sellers: clarifying where effort is warranted, where pursuit is structurally premature, and how existing GTM and BD approaches can be adjusted so progress is earned through relevance and timing rather than activity alone.

Establishing credible fit, positioning, and decision-ready context before scale

This work addresses common early misalignment issues — including unclear targeting, feature-led positioning, and assumptions about how biopharma buyers evaluate solutions.
 

• Market Entry & Approach Brief – assessment of target functions, buying behaviors, internal context, and realistic addressable market scope (TAM, SAM, SOM) to inform entry sequencing and engagement timing.
   
• Value Narrative Blueprint – buyer-specific framing of outcomes, relevance, and signals of impact for clinical, medical, scientific, and commercial stakeholders.

• Solution Positioning Map – articulation of what you solve, for whom, why it matters to buyers, and how it differs from both direct competitors and adjacent alternatives buyers already rely on.

• Messaging Guidance – application of positioning and value narratives across buyer conversations and external-facing materials, with emphasis on decision context, risk sensitivity, and credibility at first contact.

Determining where traction can responsibly extend—and where pursuit creates noise rather than signal

This work is designed for teams with activity but uneven momentum, distorted pipelines, or expansion attempts that stall outside the initial sponsor or function.

• Opportunity Identification Report –  selective prioritization of candidate accounts based on explicit fit criteria, with rationale for inclusion and exclusion—focused on buyer readiness rather than theoretical market size.

• Targeting Rubric – structured scoring framework used to evaluate pipeline fit, buyer readiness, and timing triggers before committing resources.
   
• Stakeholder Map – structured identification of likely champions, influencers, and budget-holding roles across functions—highlighting where credibility must be re-established during expansion.

• BD Strategy Framework – guidance on engagement workflow, progression criteria, and prioritization across buyer touchpoints—designed to separate interest from intent and signal from activity.

• Engagement System Review & Recommendations – review of existing BD workflows, tracking approaches, and account ownership models, with recommendations to improve transparency, continuity, and leadership-level visibility into pharma outreach, pipeline development, and account expansion activity.

• Conference ROI & Engagement Decisions – assessment of which industry meetings justify attendance based on commercial relevance, including prioritization of high-value industry roles and individuals, and guidance on pre-conference outreach and disciplined follow-up.

Evaluating whether existing models can realistically align with biopharma requirements

This work helps teams avoid pursuing opportunities that are structurally misaligned—despite surface-level interest.

• Pricing Feasibility Assessment – evaluation of pricing assumptions against buyer budget structures, approval pathways, and perceived risk—before pricing becomes a silent blocker to adoption.

• Project-Based Strategy Review – targeted periodic reassessment based on updated market signals, buyer feedback, or internal shifts in direction.

How FireTower works with teams to apply judgment, test assumptions, and refine direction

FireTower operates as an embedded strategic advisor—supporting decision-making across strategy, targeting, and engagement.

• Working Sessions – structured review and refinement of strategy, positioning, and targeting assumptions.

• Scenario Review – preparation for buyer conversations, internal decision dynamics, and likely objections—grounded in how biopharma organizations evaluate risk and relevance.